explore -WSS

explore

author：leisure time 2025-09-29 19:05:32 - browse：2879

Adam's take main illustration — Molly Ferguson/STAT

Cassava Sciences has long claimed its experimental drug, called simufilam, slows the cognitive decline of people with Alzheimer’s. On Friday, we learned how: The company recruited a large number of people into its clinical trial who don’t have Alzheimer’s.

People who almost certainly had Alzheimer’s were also included in the study, but in this group, a placebo outperformed Cassava’s drug.

The conclusion, of course, is obvious: Simufilam is inactive. It’s an inert compound no more effective than a placebo. Cassava’s assertion that simufilam is showing “disease-modifying activity” falls apart given its study was opened to people who should have been ineligible because they were misdiagnosed with Alzheimer’s. Whether that was done intentionally or unwittingly isn’t known, but it’s certainly troubling and makes the case for immediate, regulatory intervention even stronger.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： 23andMe had bad news about my health. I wish a person had delivered it
Next article： Petition to FDA: Get the lead out of consumer hair dyes

explore

WSS

Lecanemab for Alzheimer's is coming. Is the health system ready?

Color Health wants to make cancer screenings convenient

Elizabeth Holmes on track for early release from her 11

Biden launches a new push to limit health care costs

'Vaccine

Petition to FDA: Get the lead out of consumer hair dyes

hotspot

explore

hotspot

Supreme Court strikes down use of affirmative action

Beach reads and more: STAT's 2023 summer book list

Medical records are filled with copy

Study: Pain burden is higher in Black NFL players than white ones

Sports medicine is finally prioritizing gender equality

Dozens of Pride flags vandalized at Stonewall monument in NYC, 3rd time this month: Police

Cancer drug shortages should be causing more outrage

Racing yachts have close encounter with pod of orcas near Strait of Gibraltar

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Bulgari apologizes to China for listing Taiwan as a country after online backlash

hotspot

Study: Pain burden is higher in Black NFL players than white ones

Elizabeth Holmes on track for early release from her 11

Petition to FDA: Get the lead out of consumer hair dyes

Color Health wants to make cancer screenings convenient

Dozens of Pride flags vandalized at Stonewall monument in NYC, 3rd time this month: Police

New research casts further doubt on a common procedure used with IVF

explore

explore

knowledge

focus